Work

Vemurafenib Drives Epithelial-to-Mesenchymal Transition Gene Expression in BRAF Inhibitor‒Resistant BRAFV600E/NRASQ61K Melanoma Enhancing Tumor Growth and Metastasis in a Bioluminescent Murine Model

Year: 2021

Type: article

Source: Journal of Investigative Dermatology

DOI: 10.1016/j.jid.2021.10.007

Authors: Jana Jandova, Georg T. Wondrak

Institutions: University of Arizona, University of Arizona Cancer Center

Language: English

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Frederick National Laboratory for Cancer Research, National Institutes of Health, National Cancer Institute, National Institute of Environmental Health Sciences

Awards: G1361187950, G2400634982, G4966691970, Repurposing Clinical ACT Antimalarials for Experimental Melanoma Intervention, G9000066947, G9000072640, G9000190049, Southwest Environmental Health Sciences Center

OpenAlex ID: W3207423345

FWCI: 0.855

Cites: 58

Cited by: 19

Related to: 10